The Liver Health Initiative

Latest Content

The Liver Health Initiative applauds Washington, D.C. Medicaid for lifting prior authorizations that have historically restricted marginalized communities from receiving access to hepatitis treatment. Eliminating these barriers is a monumental win for health care equity and justice. We also highly encourage jurisdictional leaders to advocate for increased promotion of liver health education, to help unidentified patients understand their risk status, seek testing, and initiate treatment.

WHO and CDC have laid out some ambitious goals for the treatment of hepatitis C, and HCV co-discoverer and vaccine developer Michael Houghton, PhD, offers some insights and commentary on whether he feels it is realistic to consider the eradication of this stubborn and subtle virus.